Kronos Bio (KRON) News Today $0.96 +0.03 (+3.21%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Kronos Bio Inc Ordinary SharesDecember 13, 2024 | morningstar.comKronos Bio (NASDAQ:KRON) Shares Up 8.5% - Still a Buy?Kronos Bio (NASDAQ:KRON) Stock Price Up 8.5% - Still a Buy?December 6, 2024 | marketbeat.comStruggling Bay Area biotech firm Kronos, once worth $1B, lays off almost entire staffDecember 4, 2024 | msn.comKronos Bio announces workforce reduction of 83% by year-endNovember 28, 2024 | markets.businessinsider.comKronos Bio to lay off 83% of staff as CEO steps downNovember 28, 2024 | bizjournals.comBiotech with Cambridge lab slashes 83% of staff, CEO departsNovember 28, 2024 | bizjournals.comKronos Bio CEO Norbert Bischofberger steps down, Deborah Knobelman named interimNovember 28, 2024 | markets.businessinsider.comKronos Bio announces interim CEO; over 80% of staff reductionNovember 28, 2024 | msn.comKronos Bio Stock Jumps After Deep Workforce Cuts And CEO Shuffle: Retail Aligns With Shake-UpNovember 28, 2024 | msn.comKronos Bio Announces CEO Transition and Reduction in ForceNovember 27, 2024 | globenewswire.comPetri Dish: Kronos Bio seeks merger; Former Biogen R&D head joins investment firmNovember 22, 2024 | bizjournals.comKronos Bio Third Quarter 2024 Earnings: Beats ExpectationsNovember 16, 2024 | finance.yahoo.comKronos Bio to present preclinical data from p300 KAT inhibitor programNovember 16, 2024 | markets.businessinsider.comKronos Bio Reports Third Quarter 2024 Financial Results and Corporate Update Including Plan to Evaluate Strategic AlternativesNovember 15, 2024 | uk.finance.yahoo.comKronos Bio Highlights Preclinical Data that Show p300 KAT Inhibitors Reduce Inflammation in an Oral Presentation at ACR Convergence 2024November 14, 2024 | globenewswire.comTD Cowen downgrades Kronos Bio (KRON) to a HoldNovember 14, 2024 | markets.businessinsider.comKronos Bio downgraded to Hold from Buy at TD CowenNovember 14, 2024 | markets.businessinsider.comKronos mulls ‘strategic alternatives’ after axing cancer drug developmentNovember 14, 2024 | yahoo.comKronos Bio (NASDAQ:KRON) Rating Lowered to "Neutral" at Piper SandlerPiper Sandler lowered shares of Kronos Bio from an "overweight" rating to a "neutral" rating and decreased their price target for the company from $6.00 to $1.00 in a report on Thursday.November 14, 2024 | marketbeat.comKronos Bio (NASDAQ:KRON) Stock Rating Lowered by TD CowenTD Cowen downgraded Kronos Bio from a "buy" rating to a "hold" rating in a report on Thursday.November 14, 2024 | marketbeat.comKronos Bio files $250M mixed securities shelfNovember 8, 2024 | markets.businessinsider.comKronos Bio to present data at ASH annual meeting on p300 KAT inhibitor programNovember 5, 2024 | markets.businessinsider.comKronos Bio to Present Data at the ASH Annual Meeting from p300 KAT Inhibition Program in Multiple MyelomaNovember 5, 2024 | finance.yahoo.comKronos Bio announces preclinical data from p300 KAT inhibitor programOctober 24, 2024 | markets.businessinsider.comKronos Bio Data Presentation at EORTC-NCI-AACR Symposium Highlights the Importance of p300 KAT Inhibition in HPV-Driven TumorsOctober 23, 2024 | globenewswire.comPiper Sandler Remains a Buy on Kronos Bio (KRON)October 9, 2024 | markets.businessinsider.comKronos Bio to Present Data at the EORTC-NCI-AACR Symposium that Supports p300 KAT Inhibition in HPV-Driven TumorsOctober 9, 2024 | globenewswire.comKronos Bio (NASDAQ:KRON) Stock Quotes, Forecast and News SummaryOctober 8, 2024 | benzinga.comKronos Bio Announces Selection of Autoimmune Development Candidate for Sjögren’s DiseaseOctober 8, 2024 | markets.businessinsider.comKronos Bio Announces Selection of Autoimmune Development Candidate for Sjögren's DiseaseOctober 7, 2024 | globenewswire.comA reaction following a fire at a Georgia chemical plant is forcing evacuations and road closuresSeptember 30, 2024 | msn.comKronos Bio to Present Data at ACR Convergence 2024 to Support p300 KAT Inhibition as an Approach to Anti-Inflammatory TherapySeptember 25, 2024 | globenewswire.comKronos Bio Highlights Data at AACR Ovarian Cancer Research Symposium that Supports Clinical Evaluation of Istisociclib in Advanced Ovarian CancerSeptember 23, 2024 | globenewswire.comKronos Bio Announces Participation in Medical and Investor Conferences in SeptemberSeptember 3, 2024 | globenewswire.comIOVA Aug 2024 8.500 put (IOVA240830P00008500)August 24, 2024 | finance.yahoo.comQ3 2024 EPS Estimates for Kronos Bio, Inc. (NASDAQ:KRON) Raised by AnalystKronos Bio, Inc. (NASDAQ:KRON - Free Report) - Stock analysts at HC Wainwright boosted their Q3 2024 earnings estimates for shares of Kronos Bio in a research note issued on Monday, August 19th. HC Wainwright analyst R. Burns now anticipates that the company will earn ($0.29) per share for the quAugust 21, 2024 | marketbeat.comKronos Bio (NASDAQ:KRON) Earns Buy Rating from HC WainwrightHC Wainwright restated a "buy" rating and set a $2.25 price objective on shares of Kronos Bio in a research report on Monday.August 19, 2024 | marketbeat.comKronos Bio Second Quarter 2024 Earnings: Beats ExpectationsAugust 12, 2024 | finance.yahoo.comBuy Rating Affirmed for Kronos Bio Amid Promising Clinical Developments and Strategic ExpansionAugust 9, 2024 | markets.businessinsider.comKronos Bio Reports Second Quarter 2024 Financial Results and Pipeline UpdateAugust 9, 2024 | markets.businessinsider.comFY2025 Earnings Forecast for Kronos Bio, Inc. Issued By HC Wainwright (NASDAQ:KRON)Kronos Bio, Inc. (NASDAQ:KRON - Free Report) - Equities researchers at HC Wainwright issued their FY2025 earnings per share (EPS) estimates for Kronos Bio in a research report issued to clients and investors on Wednesday, July 31st. HC Wainwright analyst R. Burns forecasts that the company will pAugust 2, 2024 | marketbeat.comKronos Bio's (KRON) Buy Rating Reiterated at HC WainwrightHC Wainwright restated a "buy" rating and set a $2.25 target price on shares of Kronos Bio in a report on Thursday.August 1, 2024 | marketbeat.comBuy Rating on Kronos Bio Backed by Potential of KB-0742 and Solid Valuation ModelJuly 31, 2024 | markets.businessinsider.comKronos Bio Inc (KRON)July 26, 2024 | investing.comKronos Bio Announces First Patient Dosed with KB-0742 in an Expansion Cohort Focused on Platinum-Resistant High-Grade Serous Ovarian CancerJuly 23, 2024 | globenewswire.comKronos Bio, Inc. (NASDAQ:KRON) CEO Acquires $480,692.16 in StockJuly 2, 2024 | insidertrades.comNorbert W. Bischofberger Buys 881,913 Shares of Kronos Bio, Inc. (NASDAQ:KRON) StockJune 13, 2024 | insidertrades.comInsider Buying: Kronos Bio, Inc. (NASDAQ:KRON) CEO Purchases 881,913 Shares of StockKronos Bio, Inc. (NASDAQ:KRON - Get Free Report) CEO Norbert W. Bischofberger acquired 881,913 shares of Kronos Bio stock in a transaction that occurred on Wednesday, June 12th. The shares were bought at an average cost of $1.24 per share, with a total value of $1,093,572.12. Following the transaction, the chief executive officer now owns 7,375,616 shares in the company, valued at $9,145,763.84. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.June 12, 2024 | marketbeat.comKronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingMay 23, 2024 | globenewswire.comKronos Bio to Participate in Three Upcoming Healthcare Conferences and EventsMay 22, 2024 | globenewswire.com Get Kronos Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for KRON and its competitors with MarketBeat's FREE daily newsletter. Email Address Why I'm telling friends to avoid gold stocks (Ad)Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles." And if you’d like to get your hands on this, here you go, the complete breakdown. KRON Media Mentions By Week KRON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KRON News Sentiment▼0.760.60▲Average Medical News Sentiment KRON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KRON Articles This Week▼01▲KRON Articles Average Week Get Kronos Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for KRON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ATAI News Today TNYA News Today SOPH News Today ACRV News Today ACRS News Today MOLN News Today XBIT News Today BMEA News Today INBX News Today LFVN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KRON) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kronos Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kronos Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KRON Stock Alerts